Paysign (Nasdaq:PAYS) - 주가, 뉴스 및 분석

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

PAYS 주식 개요

는 기업, 소비자 및 정부 기관을 위한 선불 카드 프로그램, 포괄적인 환자 경제성 제품, 디지털 뱅킹 서비스 및 통합 결제 처리 서비스를 제공합니다.

PAYS 기본 분석
눈송이 점수
가치 평가	2/6
미래 성장	1/6
과거 실적	6/6
재무 상태	6/6
배당금	0/6

보상

수익은 연간 14.3% 증가할 것으로 예상됩니다.

지난 1년간 수익이 488.6% 증가했습니다.

분석가들은 주가가 26.6% 상승할 것이라는 데 동의합니다.

위험 분석

수익은 향후 3년간 연평균 32% 씩 감소할 것으로 예상됩니다.

지난 3개월간 상당한 내부자 매도

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Rapid Growth In Patient Affordability Market Fuels Optimism Despite Looming Margin Pressures

US$6.75

45.6% undervalued

13.92%

Revenue growth p.a.

1 day ago

Paysign, Inc. 경쟁사

Cantaloupe

NasdaqGS:CTLP

US$541.6m

Cass Information Systems

NasdaqGS:CASS

US$563.7m

International Money Express

NasdaqCM:IMXI

US$607.8m

Sezzle

NasdaqCM:SEZL

US$968.4m

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Paysign
과거 주가
현재 주가	US$3.67
52주 최고치	US$5.59
52주 최저치	US$1.67
베타	0.97
11개월 변경	-22.57%
3개월 변경 사항	-8.71%
1년 변경 사항	97.31%
33년 변화	43.92%
5년 변화	-64.58%
IPO 이후 변화	715.56%

최근 뉴스 및 업데이트

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

Sep 07

Recent updates

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

Sep 07

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 02

Paysign: Expect Rapid Growth In Its Pharma Business

Jun 30

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Apr 26

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Aug 13

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

Jun 14

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

May 16

PaySign: A 'Backdoor' $2 Stagflation Play

Mar 29

Paysign: My Top Rebound Pick For 2022

Dec 28

Paysign: The Plasma Toll Booth

Sep 23

PaySign's Post-Pandemic Payoff

Sep 07

Why PaySign Is A Very Good Company

Dec 28

PaySign: Long-Term Story Still Intact

Dec 21

Paysign reports Q3 results

Nov 17

주주 수익률

	PAYS	US Diversified Financial	US 마켓
7D	-13.4%	-0.9%	0.8%
1Y	97.3%	29.2%	33.4%

수익률 대 산업: PAYS 지난 1년 동안 18.1 %를 반환한 US Diversified Financial 산업을 초과했습니다.

수익률 대 시장: PAYS 지난 1년 동안 23.3 %를 반환한 US 시장을 초과했습니다.

가격 변동성

Is PAYS's price volatile compared to industry and market?
PAYS volatility
PAYS Average Weekly Movement	9.5%
Diversified Financial Industry Average Movement	5.4%
Market Average Movement	6.4%
10% most volatile stocks in US Market	14.8%
10% least volatile stocks in US Market	3.1%

안정적인 주가: PAYS 의 주가는 지난 3개월 동안 변동성이 심했습니다.

시간에 따른 변동성: PAYS 의 주간 변동성( 10% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립	직원	CEO	웹사이트
1995	123	Mark Newcomer	www.paysign.com

는 기업, 소비자 및 정부 기관을 위한 선불 카드 프로그램, 종합적인 환자 경제성 제품, 디지털 뱅킹 서비스 및 통합 결제 처리 서비스를 제공합니다. 제공하는 제품에는 기업 보상, 선불 기프트 카드, 범용 충전식 직불 카드, 직원 인센티브, 소비자 리베이트, 기증자 보상, 임상 시험, 의료비 환급 결제 및 의약품 결제 지원, 직불 카드로 액세스 가능한 요구불 계좌를 위한 솔루션이 포함됩니다. 이 회사는 Paysign 브랜드로 선불 카드 솔루션을 판매합니다.

Paysign, Inc. 기본 사항 요약

Paysign 의 수익과 매출은 시가총액과 어떻게 비교하나요?
PAYS 기본 통계
시가총액	US$205.11m
수익(TTM)	US$7.73m
수익(TTM)	US$53.61m

25.2x

P/E 비율

3.6x

P/S 비율

PAYS 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
PAYS 손익 계산서(TTM)
수익	US$53.61m
수익 비용	US$25.61m
총 이익	US$28.00m
기타 비용	US$20.27m
수익	US$7.73m

최근 보고된 수익

Jun 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)	0.15
총 마진	52.22%
순이익 마진	14.42%
부채/자본 비율	0%

PAYS 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

PAYS 주식 개요

보상

위험 분석

Rapid Growth In Patient Affordability Market Fuels Optimism Despite Looming Margin Pressures

Paysign, Inc. 경쟁사

NasdaqGS:CTLP

US$541.6m

NasdaqGS:CASS

US$563.7m

NasdaqCM:IMXI

US$607.8m

NasdaqCM:SEZL

US$968.4m

가격 내역 및 성능

최근 뉴스 및 업데이트

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

New minor risk - Insider selling

Consensus EPS estimates fall by 22%, revenue upgraded

Price target increased by 7.5% to US$6.58

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Recent updates

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

New minor risk - Insider selling

Consensus EPS estimates fall by 22%, revenue upgraded

Price target increased by 7.5% to US$6.58

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment improves as stock rises 34%

Paysign: Expect Rapid Growth In Its Pharma Business

Independent Director exercised options to buy US$85k worth of stock.

Consensus EPS estimates increase by 33%

Price target increased by 8.9% to US$6.13

First quarter 2024 earnings released: EPS: US$0.006 (vs US$0.003 loss in 1Q 2023)

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 30%, revenue upgraded

PaySign, Inc., Annual General Meeting, May 03, 2024

Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Price target increased by 14% to US$5.25

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CFO & Treasurer exercised options and sold US$79k worth of stock

PaySign, Inc. Announces Executive Changes

Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of the Common Stock of Paysign, Inc

Consensus EPS estimates increase by 25%

New major risk - Earnings quality

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Market cap size

Consensus EPS estimates fall by 50%

PaySign, Inc. Reaffirms Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0.004 loss in 2Q 2022)

Co-Founder exercised options and sold US$71k worth of stock

New minor risk - Market cap size

Consensus EPS estimates fall by 20%

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.006 loss in 1Q 2022)

Consensus EPS estimates increase by 36%

Price target increased by 13% to US$4.31

CFO & Treasurer recently sold US$101k worth of stock

PaySign, Inc. Elects Jeffrey B. Newman to Its Board of Directors

Consensus EPS estimates have been upgraded.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

PaySign, Inc. Provides Earnings Guidance for the Fiscal Year 2022

General Counsel exercised options to buy US$54k worth of stock.

The Recovery At PaySign Has Legs

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to US$3.75

PaySign, Inc. Provides Revenue Guidance for the Third and Fourth Quarter of 2022

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

PaySign, Inc. Provides Earnings Guidance for the Full Year of 2022

PaySign, Inc. Provides Earnings Guidance for the Full Year of 2022

Price target decreased to US$3.44

Insufficient new directors

Price target decreased to US$3.44

Insufficient new directors